6-145804978-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032145.5(FBXO30):āc.1428G>Cā(p.Glu476Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,772 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032145.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO30 | NM_032145.5 | c.1428G>C | p.Glu476Asp | missense_variant | 2/3 | ENST00000237281.5 | NP_115521.3 | |
FBXO30 | NM_001348092.2 | c.1428G>C | p.Glu476Asp | missense_variant | 2/3 | NP_001335021.1 | ||
FBXO30 | XM_047419398.1 | c.1536G>C | p.Glu512Asp | missense_variant | 2/3 | XP_047275354.1 | ||
EPM2A-DT | NR_038246.1 | n.53-23383C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO30 | ENST00000237281.5 | c.1428G>C | p.Glu476Asp | missense_variant | 2/3 | 1 | NM_032145.5 | ENSP00000237281.3 | ||
EPM2A-DT | ENST00000629681.1 | n.91-4800C>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000112 AC: 28AN: 250912Hom.: 1 AF XY: 0.000125 AC XY: 17AN XY: 135606
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461598Hom.: 1 Cov.: 60 AF XY: 0.0000536 AC XY: 39AN XY: 727084
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.1428G>C (p.E476D) alteration is located in exon 2 (coding exon 1) of the FBXO30 gene. This alteration results from a G to C substitution at nucleotide position 1428, causing the glutamic acid (E) at amino acid position 476 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at